MARKET

NAUT

NAUT

Nautilus Biotechnology Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

9.41
+0.19
+2.06%
Closed 16:00 06/22 EDT
OPEN
9.31
PREV CLOSE
9.22
HIGH
9.41
LOW
9.17
VOLUME
195.05K
TURNOVER
--
52 WEEK HIGH
25.89
52 WEEK LOW
8.85
MARKET CAP
151.27M
P/E (TTM)
-295.9119
1D
5D
1M
3M
1Y
5Y
Nautilus Biotechnology Appoints Emma Lundberg, Ph.D., to Scientific Advisory Board
Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or "Nautilus"), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the appointment of Emma Lundberg, Ph.D. to its Scientific Advisory Board (SAB), effec...
GlobeNewswire · 6d ago
The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 14)
Benzinga · 06/15 12:07
Last Week's Notable Insider Buys: Lululemon Athletica, Opendoor Technologies And More
Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. A SPAC, a REIT and some tech companies saw notable insider buying this past week. Chief executive officers were among last week's insider...
Benzinga · 06/13 19:13
Nautilus Biotechnology Debuts as Publicly Traded Company, Seeks to Deliver on the Untapped Potential of the Human Proteome
-- Business combination transaction with Arya Sciences Acquisition Corp III, a special purpose acquisition company sponsored by Perceptive Advisors, closed on June 9, 2021
GlobeNewswire · 06/10 03:02
The Past Week's Notable Insider Buys: Dun & Bradstreet, Norfolk Southern And More
Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. A SPAC, a couple of retailers and a railroad operator saw notable insider buying this past week. One chief executive officer added to two...
Benzinga · 06/06 20:15
ARYA Sciences Acquisition Corp III Announces Extraordinary General Meeting Teleconference Details
ARYA Sciences Acquisition Corp III ("ARYA") (Nasdaq: ARYA), today announced that, due to the public health and safety concerns related to the coronavirus (COVID-19) pandemic and recommendations and orders from federal and New York authorities, ARYA is stro...
GlobeNewswire · 06/01 21:44
Affinity Asset Advisors, LLC Buys BridgeBio Pharma Inc, Morphic Holding Inc, ARYA Sciences ...
GuruFocus News · 05/19 07:38
XYF leads financial gainers, BRPA and AAME among losers
Gainers: X Financial (XYF) +15%. Marathon Digital Holdings (MARA) +11%. 360 DigiTech (QFIN) +10%. FinVolution Group (FINV) +10%. ARYA Sciences Acquisition (ARYA) +9%.Losers: Big Rock Partners Acquisition (BRPA) -10%. Stable
Seekingalpha · 03/30 17:08
More
Forecast
No Data
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of NAUT. Analyze the recent business situations of Nautilus Biotechnology Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
  • Performance
  • Asset Allocation
  • Dividend History
No Data
No Data
No Data
About NAUT
Nautilus Biotechnology, Inc., formerly ARYA Sciences Acquisition Corp III, is a development stage life sciences company. The Company is engaged in creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company seeks to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. The Company is developing a prototype of a single-molecule instrument, Proteomic Analysis System. The Company’s Proteomic Analysis Platform leverages a nanofabricated, single-molecule protein array, multi-cycle imaging, and machine learning analysis to identify and measure the proteome with sensitivity and scale.

Webull offers kinds of Nautilus Biotechnology Inc stock information, including NASDAQ:NAUT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NAUT stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NAUT stock methods without spending real money on the virtual paper trading platform.